224 related articles for article (PubMed ID: 20668531)
1. PTK6 regulates IGF-1-induced anchorage-independent survival.
Irie HY; Shrestha Y; Selfors LM; Frye F; Iida N; Wang Z; Zou L; Yao J; Lu Y; Epstein CB; Natesan S; Richardson AL; Polyak K; Mills GB; Hahn WC; Brugge JS
PLoS One; 2010 Jul; 5(7):e11729. PubMed ID: 20668531
[TBL] [Abstract][Full Text] [Related]
2. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase BRK/PTK6 in ovarian cancer cells.
Fan G; Lin G; Lucito R; Tonks NK
J Biol Chem; 2013 Aug; 288(34):24923-34. PubMed ID: 23814047
[TBL] [Abstract][Full Text] [Related]
4. Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.
Falkenberg N; Anastasov N; Höfig I; Bashkueva K; Lindner K; Höfler H; Rosemann M; Aubele M
Mol Oncol; 2015 Jan; 9(1):282-94. PubMed ID: 25241146
[TBL] [Abstract][Full Text] [Related]
5. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
Hermanto U; Zong CS; Li W; Wang LH
Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
[TBL] [Abstract][Full Text] [Related]
6. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth.
Zhang W; Zong CS; Hermanto U; Lopez-Bergami P; Ronai Z; Wang LH
Mol Cell Biol; 2006 Jan; 26(2):413-24. PubMed ID: 16382134
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract][Full Text] [Related]
8. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
9. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
13. An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
Kim HIe; Lee ST
J Biol Chem; 2005 Aug; 280(32):28973-80. PubMed ID: 15961400
[TBL] [Abstract][Full Text] [Related]
14. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer.
Zheng Y; Wang Z; Bie W; Brauer PM; Perez White BE; Li J; Nogueira V; Raychaudhuri P; Hay N; Tonetti DA; Macias V; Kajdacsy-Balla A; Tyner AL
Cancer Res; 2013 Sep; 73(17):5426-37. PubMed ID: 23856248
[TBL] [Abstract][Full Text] [Related]
15. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
16. PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Shin WS; Shim HJ; Lee YH; Pyo M; Park JS; Ahn SY; Lee ST
J Cell Biochem; 2017 Sep; 118(9):2887-2895. PubMed ID: 28214294
[TBL] [Abstract][Full Text] [Related]
17. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
18. The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer.
Wang XJ; Xiong Y; Ma ZB; Xia JC; Li YF
Chin J Cancer; 2016 Jun; 35(1):54. PubMed ID: 27311570
[TBL] [Abstract][Full Text] [Related]
19. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.
Sprynski AC; Hose D; Caillot L; Réme T; Shaughnessy JD; Barlogie B; Seckinger A; Moreaux J; Hundemer M; Jourdan M; Meissner T; Jauch A; Mahtouk K; Kassambara A; Bertsch U; Rossi JF; Goldschmidt H; Klein B
Blood; 2009 May; 113(19):4614-26. PubMed ID: 19228610
[TBL] [Abstract][Full Text] [Related]
20. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]